サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1709458

脂質ナノ粒子原材料の世界市場：材料の種類別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Lipid Nanoparticle Raw Materials Market, By Material Type, By Application, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 303 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
脂質ナノ粒子原材料の世界市場：材料の種類別・用途別・エンドユーザー別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年03月04日
発行: AnalystView Market Insights
ページ情報: 英文 303 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

脂質ナノ粒子原材料の市場規模は2024年に2億4,598万米ドルとなり、2025年から2032年にかけてCAGR 5.90%で拡大

脂質ナノ粒子原材料の市場力学

mRNAベースの治療と先進ドラッグデリバリーに対する需要の高まり

mRNAベースの治療と先進ドラッグデリバリーに対する需要の高まりは、脂質ナノ粒子（LNP）原料市場の主要促進要因です。LNPは、mRNA分子を安全かつ効果的に細胞内に送達するために極めて重要であり、さまざまな疾患の治療における画期的な進歩を可能にしています。mRNAのCOVID-19ワクチンの成功は、LNPベースの送達システムの可能性を浮き彫りにし、さらなる研究と投資の原動力となっています。ワクチンだけでなく、mRNA技術はがん免疫療法、希少遺伝子疾患、個別化医療にも応用が検討されており、高品質な脂質成分の必要性が高まっています。

製薬会社やバイオテクノロジー企業がmRNAパイプラインを進めるにつれて、イオン化可能な脂質、リン脂質、PEG脂質の需要が高まっています。さらに、LNPは低分子干渉RNA（siRNA）やCRISPRのような遺伝子編集ツールの送達に利用され、応用範囲が広がっています。安定性、有効性、安全性を高めるための脂質製剤の絶え間ない技術革新が、市場の拡大をさらに後押ししています。mRNAベースの医薬品の臨床試験と規制当局の承認が増加する中、LNP原料市場は着実な成長を遂げています。

脂質ナノ粒子原材料市場：主な考察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2025-2032年）に約5.90％のCAGRで毎年成長すると推定されています。

材料の種類別では、イオン化可能脂質が2024年に最大市場シェアを示すと予測されました。

用途別では、mRNAワクチンが2024年の主要用途です。

エンドユーザー別は、2024年には製薬会社が主要なエンドユーザーでした。

地域別では、アジア太平洋地域が2024年の売上高をリードしています。

脂質ナノ粒子原材料市場：セグメンテーション分析

世界の脂質ナノ粒子原材料市場は、材料の種類、用途、エンドユーザー、地域に基づいてセグメント化されます。

市場は材料の種類に基づいて5つのカテゴリーに分けられる：イオン化可能脂質、リン脂質、コレステロール、ポリエチレングリコール（PEG）脂質、ヘルパー脂質です。イオン化可能脂質は、mRNAのような遺伝物質を細胞内に送達する上で重要な役割を果たすため、脂質ナノ粒子（LNP）原料市場を独占しています。これらの脂質は、mRNAを分解から守り、効率的な細胞への取り込みを促進する安定したナノ粒子の形成に不可欠です。エンドソームのような酸性環境では正電荷を帯びるというユニークな性質は、治療用カーゴを細胞内に放出するのに役立ちます。mRNAベースのCOVID-19ワクチンの成功は、イオン化可能な脂質の需要を大幅に押し上げました。さらに、遺伝子編集、がん免疫療法、希少疾患治療などの新たな用途にも不可欠です。製薬会社は、ドラッグデリバリーにおける有効性と安全性を確保するため、高純度のイオン化可能脂質を優先しています。継続的な調査により、生分解性を改善し、毒性を低減するための技術革新が推進されています。mRNAベースの治療法の急速な成長により、イオン化可能脂質はLNP原料市場における優位性を維持すると予想されます。

市場は用途別に、mRNAワクチン、遺伝子治療、がんドラッグデリバリー、タンパク質・ペプチドデリバリー、希少疾患治療の5つのカテゴリーに分類されます。mRNAワクチンは、COVID-19のような感染症との闘いにおける成功が原動力となり、脂質ナノ粒子（LNP）原料市場を独占しています。LNPはmRNAを分解から保護し、細胞内への効率的な送達を確保する上で重要な役割を果たしており、ワクチンの有効性に不可欠なものとなっています。COVID-19ワクチンの世界の成功は、インフルエンザ、ジカ熱、その他の疾患に対する将来のmRNAベース・ワクチンにLNP技術を使用する前例となりました。製薬会社はmRNAワクチンパイプラインの拡充に多額の投資を行っており、LNP原料の需要をさらに高めています。さらに、mRNAワクチンは、腫瘍を標的とする免疫系を訓練することができる個別化がんワクチンの牽引役となっています。LNP製剤の安定性を高め、毒性を低減し、高温での保存を可能にするため、継続的な研究が行われています。パンデミックへの備えと迅速なワクチン開発への注目が高まる中、mRNAワクチンはLNP原料の主要用途であり続けると予想されます。

脂質ナノ粒子原材料市場：地域別分析

アジア太平洋地域は、医薬品とバイオテクノロジーの進歩の増加により、LNP原料市場で急速な成長を遂げています。中国、日本、韓国、インドなどの国々がmRNAベースの研究開発をリードしています。ワクチン生産と遺伝子治療への投資の増加が脂質原料の需要を押し上げています。バイオテクノロジーの革新と現地生産を支援する政府のイニシアチブが市場拡大を加速しています。この地域には開発・製造受託機関の強力なネットワークがあり、大規模生産を後押ししています。mRNAベースの治療に対する臨床試験の増加が、市場の成長をさらに後押ししています。学術機関や研究センターは、LNP技術を発展させるために製薬会社と積極的に協力しています。ヘルスケア支出の増加と個別化医療の需要が新たな機会を生み出しています。同地域はまた、コスト効率の高い製造環境の恩恵を受けており、生産提携のために世界企業を惹きつけています。全体として、アジア太平洋は技術革新、投資、mRNA用途の拡大により、LNP原料の主要拠点として台頭しつつあります。

中国は、バイオテクノロジーと製薬研究の進歩により、アジア太平洋におけるLNP原料市場の成長に大きく貢献しています。同国では、特に新興諸国のパンデミック中とその後にmRNAベースのワクチン開発が急増し、イオン化可能脂質、リン脂質、PEG脂質の需要を押し上げています。国内での医薬品製造と技術革新を促進する資金援助や政策による政府の強力な支援が、市場の成長を加速させています。中国では開発製造受託機関（CDMO）のネットワークが拡大しており、LNP原料の大規模生産と輸出を促進しています。大手大学や研究機関は、次世代ドラッグデリバリーシステムを開発するためにバイオテクノロジー企業と協力しています。遺伝子治療、がん治療、希少疾患研究への投資の増加は、LNP成分の需要をさらに高めています。競争力のある製造コストと高度なインフラが、世界の製薬企業との提携を引き寄せています。さらに、mRNAベースの治療薬の臨床試験と承認の増加により、中国は世界のLNP原料市場における主要プレーヤーとしての地位を固めています。

脂質ナノ粒子原材料市場：競合情勢

脂質ナノ粒子（LNP）原料市場は競争が激しく、主要プレーヤーは技術革新、戦略的提携、生産能力の拡大に注力しています。CordenPharmaとAvanti Polar Lipidsは高純度脂質の著名なプロバイダーで、mRNAワクチン製造のために大手製薬会社に製品を供給しています。Merck KGaAとEvonik Industriesは、大規模生産をサポートする高度な技術を活用し、脂質製造をリードしています。Lipoid GmbHは、ドラッグデリバリーにおける脂質製剤に不可欠なリン脂質の供給に特化しています。アキュイタス・セラピューティクスは独自のLNP技術で有名で、mRNAを用いた治療に広く使われています。ジェネバント・サイエンシズ社は、遺伝子編集療法の送達効率を向上させるため、新規の脂質製剤を開発しています。

ポリムン・サイエンティフィックはカスタマイズされた脂質成分を提供し、ワクチン開発企業との強い結びつきがあります。クロダ・インターナショナルは子会社のアバンティ・ポーラー・リピッドを通じ、世界の需要増に対応するため生産能力を拡大しています。日本ファインケミカルとIOI Oleo GmbHは、製剤の安定性と有効性に不可欠な特殊脂質を供給しています。T&Tサイエンティフィックとクリエイティブ・バイオラボは、研究用と臨床用の費用対効果の高い脂質ソリューションの開発に注力しています。ケイマンケミカルとエシュロン・バイオサイエンシズは、特殊脂質試薬で学術・産業研究をサポートしています。

目次

第1章 脂質ナノ粒子原材料市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 脂質ナノ粒子原材料の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 脂質ナノ粒子原材料市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 脂質ナノ粒子原材料市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 脂質ナノ粒子原材料の市場情勢

  • 脂質ナノ粒子原材料の市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 脂質ナノ粒子原材料市場：材料の種類別

  • 概要
    • セグメント別シェア分析：材料の種類別
    • イオン化脂質
    • リン脂質
    • コレステロール
    • ポリエチレングリコール（PEG）脂質
    • ヘルパー脂質

第8章 脂質ナノ粒子原材料市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • mRNAワクチン
    • 遺伝子治療
    • 腫瘍用ドラッグデリバリー
    • タンパク質・ペプチド送達
    • 希少疾患治療

第9章 脂質ナノ粒子原材料市場：エンドユーザー別

  • 概要
    • セグメント別シェア分析：エンドユーザー別
    • 製薬会社
    • バイオテクノロジー企業
    • CDMO (受託開発製造機関)
    • 研究・学術機関

第10章 脂質ナノ粒子原材料市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ（LATAM）
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ（MEA）
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：脂質ナノ粒子原材料業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • CordenPharma
    • Avanti Polar Lipids
    • Precision NanoSystems
    • Merck KGaA
    • Lipoid GmbH
    • Evonik Industries
    • Genevant Sciences
    • Acuitas Therapeutics
    • Polymun Scientific
    • Nippon Fine Chemical
    • Cayman Chemical
    • T&T Scientific
    • IOI Oleo GmbH
    • Croda International
    • Creative Biolabs
    • Echelon Biosciences
    • PTS Inc.

第12章 AnalystViewの全方位的分析

目次
Product Code: ANV4906

REPORT HIGHLIGHT

Lipid Nanoparticle Raw Materials Market size was valued at US$ 245.98 Million in 2024, expanding at a CAGR of 5.90% from 2025 to 2032.

The Lipid Nanoparticle (LNP) Raw Materials Market focuses on the essential components used in producing lipid nanoparticles, which are vital for drug delivery systems, especially in mRNA-based therapies and vaccines. LNPs are composed of lipids such as ionizable lipids, phospholipids, cholesterol, and polyethylene glycol (PEG) lipids, which encapsulate and protect therapeutic molecules. The demand for these raw materials has surged due to the success of mRNA COVID-19 vaccines and advancements in gene therapy. Pharmaceutical and biotechnology companies are major consumers, driving market growth. Research into personalized medicine and cancer treatment also contributes to rising demand. North America and Europe dominate the market due to strong pharmaceutical industries, while Asia-Pacific shows rapid growth. Challenges include the high cost of raw materials and complex manufacturing processes. However, innovations in lipid chemistry and large-scale production techniques are addressing these issues. Overall, the market is expanding as LNPs become essential in next-generation therapeutics.

Lipid Nanoparticle Raw Materials Market- Market Dynamics

Rising demand for mRNA-based therapies and advanced drug delivery

Rising demand for mRNA-based therapies and advanced drug delivery is a key driver for the lipid nanoparticle (LNP) raw materials market. LNPs are crucial for delivering mRNA molecules safely and effectively into cells, enabling breakthroughs in treatments for various diseases. The success of mRNA COVID-19 vaccines has highlighted the potential of LNP-based delivery systems, driving further research and investment. Beyond vaccines, mRNA technology is being explored for cancer immunotherapy, rare genetic disorders, and personalized medicine, increasing the need for high-quality lipid components.

As pharmaceutical companies and biotech firms advance their mRNA pipelines, demand for ionizable lipids, phospholipids, and PEG lipids grows. Additionally, LNPs are gaining traction for delivering small interfering RNA (siRNA) and gene-editing tools like CRISPR, broadening their application scope. Continuous innovation in lipid formulations to enhance stability, efficacy, and safety further fuels market expansion. With increasing clinical trials and regulatory approvals for mRNA-based drugs, the market for LNP raw materials is experiencing steady growth.

Lipid Nanoparticle Raw Materials Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2025-2032)

Based on Material Type segmentation, Ionizable Lipids was predicted to show maximum market share in the year 2024

Based on application segmentation, mRNA vaccines were the leading application in 2024

Based on End-user segmentation, Pharmaceutical Companies vaccines were the leading End-user in 2024

On the basis of region, Asia Pacific was the leading revenue generator in 2024

Lipid Nanoparticle Raw Materials Market- Segmentation Analysis:

The Global Lipid Nanoparticle Raw Materials Market is segmented on the basis of Material Type, Application, End-user, and Region.

The market is divided into five categories based on Material Type: Ionizable Lipids, Phospholipids, Cholesterol, Polyethylene Glycol (PEG) Lipids, Helper Lipids. Ionizable lipids dominate the lipid nanoparticle (LNP) raw materials market due to their critical role in delivering genetic material, such as mRNA, into cells. These lipids are essential for forming stable nanoparticles that protect mRNA from degradation and facilitate efficient cellular uptake. Their unique property of being positively charged in acidic environments, such as endosomes, helps release therapeutic cargo into the cell. The success of mRNA-based COVID-19 vaccines has significantly boosted demand for ionizable lipids. Additionally, they are vital in emerging applications like gene editing, cancer immunotherapy, and rare disease treatments. Pharmaceutical companies prioritize high-purity ionizable lipids to ensure efficacy and safety in drug delivery. Continuous research is driving innovations to improve their biodegradability and reduce toxicity. With the rapid growth of mRNA-based therapies, ionizable lipids are expected to maintain their dominance in the LNP raw materials market.

The market is divided into five categories based on application: mRNA Vaccines, Gene Therapy, Oncology Drug Delivery, Protein and Peptide Delivery, Rare Disease Treatment. mRNA vaccines dominate the lipid nanoparticle (LNP) raw materials market, driven by their success in combating infectious diseases like COVID-19. LNPs play a vital role in protecting mRNA from degradation and ensuring efficient delivery into cells, making them essential for vaccine efficacy. The global success of COVID-19 vaccines has set a precedent for using LNP technology in future mRNA-based vaccines for influenza, Zika, and other diseases. Pharmaceutical companies are heavily investing in expanding mRNA vaccine pipelines, further increasing demand for LNP raw materials. Additionally, mRNA vaccines are gaining traction for personalized cancer vaccines, where they can train the immune system to target tumors. Continuous research is focused on improving LNP formulations to enhance stability, reduce toxicity, and enable storage at higher temperatures. With the growing focus on pandemic preparedness and rapid vaccine development, mRNA vaccines are expected to remain the leading application for LNP raw materials.

Lipid Nanoparticle Raw Materials Market- Geographical Insights

The Asia-Pacific region is experiencing rapid growth in the LNP raw materials market, driven by increasing pharmaceutical and biotechnology advancements. Countries like China, Japan, South Korea, and India are leading in mRNA-based research and development. Growing investments in vaccine production and gene therapy are boosting demand for lipid raw materials. Government initiatives supporting biotechnology innovation and local manufacturing are accelerating market expansion. The region has a strong network of contract development and manufacturing organizations, driving large-scale production. Rising clinical trials for mRNA-based treatments are further contributing to market growth. Academic institutions and research centers are actively collaborating with pharmaceutical firms to advance LNP technologies. Increasing healthcare expenditure and demand for personalized medicine are creating new opportunities. The region also benefits from a cost-effective manufacturing environment, attracting global companies for production partnerships. Overall, Asia-Pacific is emerging as a key hub for LNP raw materials due to innovation, investments, and growing mRNA applications.

China is a major contributor to the growth of the LNP raw materials market in Asia-Pacific, driven by advancements in biotechnology and pharmaceutical research. The country has witnessed a surge in mRNA-based vaccine development, especially during and after the COVID-19 pandemic, boosting demand for ionizable lipids, phospholipids, and PEG lipids. Strong government support through funding and policies promoting domestic drug manufacturing and innovation is accelerating market growth. China's growing network of contract development and manufacturing organizations (CDMOs) is driving large-scale production and export of LNP raw materials. Leading universities and research institutions are collaborating with biotech firms to develop next-generation drug delivery systems. Rising investments in gene therapy, cancer treatment, and rare disease research are further increasing demand for LNP components. The country's competitive manufacturing costs and advanced infrastructure are attracting global pharmaceutical partnerships. Additionally, increasing clinical trials and approvals for mRNA-based therapeutics are solidifying China's position as a key player in the global LNP raw materials market.

Lipid Nanoparticle Raw Materials Market- Competitive Landscape:

The lipid nanoparticle (LNP) raw materials market is highly competitive, with key players focusing on innovation, strategic collaborations, and expanding production capacities. CordenPharma and Avanti Polar Lipids are prominent providers of high-purity lipids, catering to major pharmaceutical companies for mRNA vaccine production. Merck KGaA and Evonik Industries lead in lipid manufacturing, leveraging advanced technologies to support large-scale production. Lipoid GmbH specializes in supplying phospholipids, essential for lipid formulations in drug delivery. Acuitas Therapeutics is renowned for its proprietary LNP technology, widely used in mRNA-based therapies. Genevant Sciences is advancing novel lipid formulations to improve delivery efficiency for gene-editing therapies.

Polymun Scientific provides customized lipid components and has strong ties with vaccine developers. Croda International, through its subsidiary Avanti Polar Lipids, is expanding its production capacity to meet growing global demand. Nippon Fine Chemical and IOI Oleo GmbH supply specialty lipids essential for stability and efficacy in formulations. T&T Scientific and Creative Biolabs focus on developing cost-effective lipid solutions for research and clinical use. Cayman Chemical and Echelon Biosciences support academic and industrial research with specialized lipid reagents.

Recent Developments:

In December 2023, BroadPharm completed a major expansion effort, doubled its facility, expanded advanced products and bioconjugation services, bolstered capacity, addressed rising pharmaceutical and biotech sector demands.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LIPID NANOPARTICLE RAW MATERIALS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • CordenPharma
  • Avanti Polar Lipids
  • Precision NanoSystems
  • Merck KGaA
  • Lipoid GmbH
  • Evonik Industries
  • Genevant Sciences
  • Acuitas Therapeutics
  • Polymun Scientific
  • Nippon Fine Chemical
  • Cayman Chemical
  • T&T Scientific
  • IOI Oleo GmbH
  • Croda International
  • Creative Biolabs
  • Echelon Biosciences
  • PTS Inc.

GLOBAL LIPID NANOPARTICLE RAW MATERIALS MARKET, BY MATERIAL TYPE- MARKET ANALYSIS, 2019 - 2032

  • Ionizable Lipids
  • Phospholipids
  • Cholesterol
  • Polyethylene Glycol (PEG) Lipids
  • Helper Lipids

GLOBAL LIPID NANOPARTICLE RAW MATERIALS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • mRNA Vaccines
  • Gene Therapy
  • Oncology Drug Delivery
  • Protein and Peptide Delivery
  • Rare Disease Treatment

GLOBAL LIPID NANOPARTICLE RAW MATERIALS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Development and Manufacturing Organizations
  • Research and Academic Institutions

GLOBAL LIPID NANOPARTICLE RAW MATERIALS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Lipid Nanoparticle Raw Materials Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Lipid Nanoparticle Raw Materials Market Snippet by Material Type
    • 2.1.2. Lipid Nanoparticle Raw Materials Market Snippet by Application
    • 2.1.3. Lipid Nanoparticle Raw Materials Market Snippet by End-user
    • 2.1.4. Lipid Nanoparticle Raw Materials Market Snippet by Country
    • 2.1.5. Lipid Nanoparticle Raw Materials Market Snippet by Region
  • 2.2. Competitive Insights

3. Lipid Nanoparticle Raw Materials Key Market Trends

  • 3.1. Lipid Nanoparticle Raw Materials Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Lipid Nanoparticle Raw Materials Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Lipid Nanoparticle Raw Materials Market Opportunities
  • 3.4. Lipid Nanoparticle Raw Materials Market Future Trends

4. Lipid Nanoparticle Raw Materials Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Lipid Nanoparticle Raw Materials Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Lipid Nanoparticle Raw Materials Market Landscape

  • 6.1. Lipid Nanoparticle Raw Materials Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Lipid Nanoparticle Raw Materials Market - By Material Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Material Type, 2024 & 2032 (%)
    • 7.1.2. Ionizable Lipids
    • 7.1.3. Phospholipids
    • 7.1.4. Cholesterol
    • 7.1.5. Polyethylene Glycol (PEG) Lipids
    • 7.1.6. Helper Lipids

8. Lipid Nanoparticle Raw Materials Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. mRNA Vaccines
    • 8.1.3. Gene Therapy
    • 8.1.4. Oncology Drug Delivery
    • 8.1.5. Protein and Peptide Delivery
    • 8.1.6. Rare Disease Treatment

9. Lipid Nanoparticle Raw Materials Market - By End-user

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
    • 9.1.2. Pharmaceutical Companies
    • 9.1.3. Biotechnology Companies
    • 9.1.4. Contract Development and Manufacturing Organizations
    • 9.1.5. Research and Academic Institutions

10. Lipid Nanoparticle Raw Materials Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Lipid Nanoparticle Raw Materials Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Lipid Nanoparticle Raw Materials Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Lipid Nanoparticle Raw Materials Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Lipid Nanoparticle Raw Materials Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Lipid Nanoparticle Raw Materials Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Lipid Nanoparticle Raw Materials Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. CordenPharma
    • 11.2.2. Avanti Polar Lipids
    • 11.2.3. Precision NanoSystems
    • 11.2.4. Merck KGaA
    • 11.2.5. Lipoid GmbH
    • 11.2.6. Evonik Industries
    • 11.2.7. Genevant Sciences
    • 11.2.8. Acuitas Therapeutics
    • 11.2.9. Polymun Scientific
    • 11.2.10. Nippon Fine Chemical
    • 11.2.11. Cayman Chemical
    • 11.2.12. T&T Scientific
    • 11.2.13. IOI Oleo GmbH
    • 11.2.14. Croda International
    • 11.2.15. Creative Biolabs
    • 11.2.16. Echelon Biosciences
    • 11.2.17. PTS Inc.

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us